Kathleen M Mahoney
5PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 06, 2023
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.Anthony W Tolcher, Michael Gordon, Kathleen M Mahoney
|Feb 08, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumab.Kathleen M Mahoney, Petra Ross-Macdonald, Long Yuan
|Oct 12, 2021
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses.Xia Bu, Vikram R Juneja, Carol G Reynolds
|Jan 23, 2020
The importance of exosomal PDL1 in tumour immune evasion.Dhouha Daassi, Kathleen M Mahoney, Gordon J Freeman
|Dec 20, 2018
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.Kathleen M Mahoney, Sachet A Shukla, Nikolaos Patsoukis
Pageof 1
Frequent Collaborators
4 joint publications
Gordon J Freeman
1 joint publications
Sachet A Shukla
1 joint publications
Nikolaos Patsoukis
1 joint publications
Apoorvi Chaudhri
1 joint publications
Edward P Browne
1 joint publications
Thomas M Eisenhaure
1 joint publications
Nir Hacohen
1 joint publications
Vassiliki A Boussiotis
1 joint publications
Catherine J Wu
1 joint publications
Dhouha Daassi
